+143.3%
MRNA vs FCEL
+139.5%
+3.8%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 6mo.
| Period | Portfolio | FCEL | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | -6.7% | +3.3% | -3.1% |
| 7D | -10.1% | +15.1% | -25.1% | -10.6% |
| 30D | +126.7% | -16.4% | +143.2% | +125.7% |
| 3M | +184.1% | -5.3% | +189.4% | +174.0% |
| 6M | +143.3% | +124.5% | +18.8% | +101.4% |
| All | +143.3% | +139.5% | +3.8% | +101.4% |
Cumulative growth
Daily Returns
Daily percentage return beside FCEL.
Daily Out/Under-Performance
Portfolio return minus FCEL return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × FCEL return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 6mo: compounded portfolio wealth divided by compounded FCEL wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
6mo analysis · Full analysis span regression · 6 months rolling